Quality of life after islet transplantation: data from the GRAGIL 1 and 2 trials

被引：43

作者：

Benhamou, P. Y. ^{[1
]}

Milliat-Guittard, L. ^{[2
,10
]}

Wojtusciszyn, A. ^{[3
]}

Kessler, L. ^{[4
,11
]}

Toso, C. ^{[5
]}

Baertschiger, R. ^{[5
]}

Debaty, I.

Badet, L. ^{[9
]}

Penfornis, A. ^{[6
]}

Thivolet, C. ^{[7
,10
,12
]}

Renard, E. ^{[3
]}

Bayle, F. ^{[8
]}

Morel, P. ^{[5
]}

Morelon, E. ^{[9
,10
]}

Colin, C. ^{[2
,10
]}

Berney, T. ^{[5
]}

机构：

[1] CHU Grenoble, Dept Endocrinol, Clin Endocrinol, F-38043 Grenoble, France

[2] Univ Lyon, EA Sante Individu Soc 4129, Lyon, France

[3] Ctr Hosp Montpellier, Serv Endocrinol, Montpellier, France

[4] Univ Strasbourg, Fac Med, Strasbourg, France

[5] Univ Hosp Geneva, Dept Surg, Geneva, Switzerland

[6] Hop Jean Minjoz, Serv Endocrinol Metab & Diabet Nutr, F-25030 Besancon, France

[7] Univ Lyon, Fac Laennec, INSERM, U449, Lyon, France

[8] CHU Grenoble, Serv Nephrol, F-38043 Grenoble, France

[9] Hosp Civiles Lyon, Serv Nephrol Med Transplantat & Immunol, Clin Pavillon P, Lyon, France

[10] Univ Lyon 1, F-69365 Lyon, France

[11] Hop Univ Strasbourg, Serv Endocrinol Diabet & Malad Metabol, Strasbourg, France

[12] Hosp Civils Lyon, Serv Endocrinol Diabete Nutr Pavillon X, Lyon, France

来源：

DIABETIC MEDICINE | 2009年 / 26卷 / 06期

关键词：

health-related quality of life; pancreatic islet transplantation; Type 1 diabetes mellitus;

D O I：

10.1111/j.1464-5491.2009.02731.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Rigorous assessment of health-related quality of life (HRQL) is mandatory to establish the benefits of islet transplantation. The 36-Item Short Form Health Survey (SF-36) and the Diabetes Quality of Life (DQOL) scales were completed by patients included in an Islet Transplantation Alone (ITA) trial (n = 10) and an Islet After Kidney (IAK) trial (n = 10). The two populations differed by HRQL scores at baseline, with poorer scores in ITA patients. SF-36 scores for physical limitations, bodily pain, general health perception, social functioning, and health transition improved significantly in ITA patients 6 and 12 months post transplantation. The DQOL global score was significantly improved at 6 months and remained so at 12 months, because of a significant improvement in the dimensions of satisfaction and impact of diabetes. No improvement was observed in the IAK patients. HRQL assessment may help in the selection of candidates with brittle diabetes for islet transplantation.

引用

页码：617 / 621

页数：5

共 50 条

[21] THE FREQUENCY AND QUALITY OF REPORTING OF QUALITY OF LIFE DATA IN TRIALS OF IMMUNOSUPPRESSIVE DRUG REGIMENS IN KIDNEY TRANSPLANTATION
Martin, Howell
Germaine, Wong
Allison, Tong
Tek, Tan Ho
Jonathan, Craig
Kirsten, Howard
IMMUNOLOGY AND CELL BIOLOGY, 2012, 90 (08): : A31 - A32
[22] Islet after kidney (IAK) transplantation in patients with type 1 diabetes using a novel immunosupprfssion protocol: Prfliminary results of the GRAGIL 1B multicenter trial
Bemey, T
Bucher, P
Kessler, L
Penfomis, A
Badet, L
Thivolet, C
Bayle, F
Milliat-Guittard, L
Brun, JM
Rifle, G
Kessler, M
Atlan, C
Oberholzer, J
Colin, C
Philippe, J
Morel, P
Benhamou, PY
TRANSPLANTATION, 2003, 76 (04) : S23 - S23
[23] Type-1 Diabetes: Islet Cell Transplantation improves Quality of Life Comment
Ritzel, Robert
DIABETOLOGIE UND STOFFWECHSEL, 2018, 13 (04)
[24] Improved Long-Term Health-Related Quality of Life After Islet Transplantation
Tharavanij, Thipaporn
Betancourt, Arthur
Messinger, Shari
Cure, Pablo
Leitao, Cristiane B.
Baidal, David A.
Froud, Tatiana
Ricordi, Camillo
Alejandro, Rodolfo
TRANSPLANTATION, 2008, 86 (09) : 1161 - 1167
[25] Suggestions for the presentation of quality of life data from clinical trials
Machin, D
Weeden, S
STATISTICS IN MEDICINE, 1998, 17 (5-7) : 711 - 724
[26] Human islet transplantation network for the treatment of Type I diabetes: First data from the Swiss-French GRAGIL consortium (1999-2000)
Benhamou P.Y.
Oberholzer J.
Toso C.
Kessler L.
Penfornis A.
Bayle F.
Thivolet C.
Martin X.
Ris F.
Badet L.
Colin C.
Morel P.
on behalf of the GRAGIL
Diabetologia, 2001, 44 (7) : 859 - 864
[27] Human islet transplantation network for the treatment of Type I diabetes: first data from the Swiss-French GRAGIL consortium (1999-2000)
Benhamou, PY
Oberholzer, J
Toso, C
Kessler, L
Penfornis, A
Bayle, F
Thivolet, C
Martin, X
Ris, F
Badet, L
Colin, C
Morel, P
DIABETOLOGIA, 2001, 44 (07) : 859 - 864
[28] Patients with type 1 diabetes: quality of life after islet of langerhans allotransplantation
Milliat-Guittard, Laure
Benhamou, Pierre-Yves
Wojtusciszyn, Anne
Berney, Thierry
Kessler, Laurence
Badet, Lionel
Penfornis, Alfred
Thivolet, Charles
Renard, Eric
Colin, Cyrille
XENOTRANSPLANTATION, 2007, 14 (05) : 474 - 475
[29] PANCREAS AND ISLET TRANSPLANTATION .2. CLINICAL-TRIALS
SUTHERLAND, DER
DIABETOLOGIA, 1981, 20 (04) : 435 - 450
[30] Identifying the types of missingness in quality of life data from clinical trials
Curran, D
Bacchi, M
Schmitz, SFH
Molenberghs, G
Sylvester, RJ
STATISTICS IN MEDICINE, 1998, 17 (5-7) : 739 - 756

← 1 2 3 4 5 →